Jul 27, 2026 07:01AM
Jun 22, 2026 06:46AM
Jun 16, 2026 07:13AM
Jun 16, 2026 06:47AM
Jun 15, 2026 08:01AM
May 7, 2026 07:48AM
Mar 30, 2026 04:23PM Guggenheim Reiterates Buy Rating on Neumora Therapeutics (NMRA) following Q4 results
Mar 30, 2026 10:58AM
Mar 30, 2026 07:19AM
Feb 17, 2026 06:28AM
Jan 12, 2026 02:27AM
Jan 7, 2026 01:20PM
Jan 5, 2026 09:51AM
Jan 5, 2026 06:45AM Neumora plans clinical trials, data readouts through 2026
Dec 1, 2025 05:08AM
Nov 17, 2025 04:24AM
Nov 6, 2025 08:19AM
Oct 27, 2025 07:57AM
Oct 27, 2025 06:30AM
Oct 23, 2025 06:50AM
Sep 15, 2025 04:41PM JPMorgan Downgrades Neumora Therapeutics (NMRA) to Underweight
Aug 7, 2025 10:00AM
Aug 6, 2025 05:09PM
Jul 16, 2025 05:52AM
Jul 10, 2025 06:50AM
Jul 9, 2025 07:03AM
May 13, 2025 07:05AM
Apr 29, 2025 07:28AM H.C. Wainwright Reiterates Buy Rating on Neumora Therapeutics (NMRA)
Apr 16, 2025 01:02PM
Apr 7, 2025 12:55PM
Apr 5, 2025 01:11PM
Apr 4, 2025 12:35PM
Apr 3, 2025 04:00PM
Apr 2, 2025 04:04PM
Apr 2, 2025 01:38AM Deutsche Bank Downgrades H Lundbeck A/S (HLUNB:DC) (HLUYY) to Hold
Apr 2, 2025 01:10AM
Apr 1, 2025 08:35PM
Apr 1, 2025 01:55PM
Mar 31, 2025 08:30PM
Mar 29, 2025 04:32PM
Mar 28, 2025 04:32PM
Mar 28, 2025 04:00PM NMRA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Neumora Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Mar 27, 2025 04:27PM
Mar 27, 2025 11:18AM
Mar 26, 2025 04:22PM
Mar 24, 2025 04:13PM
Mar 23, 2025 04:00PM
Mar 23, 2025 02:02PM
Mar 22, 2025 12:23PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Neumora Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - NMRA
Mar 21, 2025 12:18PM

423,224 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All